Archive

Abstract

To investigate the perspectives of peritoneal dialysis patients regarding their body image, assess their quality of life, and evaluate their emotional intelligence levels, providing valuable insights for their care and support. Methods. This study analysed data from 739 ESRD patients registered in the Chinese National Renal Data System between 2010 and 2018. Results. Compared to hemodialysis patients, Peritoneal dialysis patients had a higher level of emotional intelligence and a lower level of mental health. In addition, compared to Hemodialysis patients, patients with Peritoneal dialysis had poorer dietary behaviour, nutrient intake, and nutritional status. Conclusions. The research highlights the need to enhance the quality of lives of dialysis patients, with a focus on elderly individuals and those with peptic ulcer disease, and highlights the potential benefits of Peritoneal in this context. The study explores the implications of peritonitis, fluid choice, and PD membrane status on TF.

Keywords

Hemodialysis, Peritoneal dialysis, Kidney care ,Chronic renal failure.

Reference

  1. Azar, A.T. (Ed.) (2013), Modelling and Control of Dialysis Systems (SCI 404), 3–43. Springer-Verlag Berlin Heidelberg DOI: 10.1007/978-3-642-27458-9
  2. Vanholder, R.; Argiles, A.; Jankowski, J. European Uraemic Toxin Work G. A history of uraemic toxicity and of the European Uraemic Toxin Work Group (EUTox). Clin. Kidney J. 2021, 14, 1514–1523.
  3. Himmelfarb, J.; Vanholder, R.; Mehrotra, R.; Tonelli, M. The current and future landscape of dialysis. Nat. Rev. Nephrol. 2020, 16, 573–585.
  4. Twardowski, Z.J. History of Peritoneal Access Development. Int. J. Artif. Organs 2006, 29, 2–40.
  5. Liyanage, T.; Ninomiya, T.; Jha, V.; Neal, B.; Patrice, H.M.; Okpechi, I.; Zhao, M.-h.; Lv, J.; Garg, A.X.; Knight, J.; et al. World-wide access to treatment for end-stage kidney disease: A systematic review. Lancet 2015, 385, 1975–1982.
  6. Christensen AJ, Ehlers SL. Psychological factors in end?stage renal disease: an emerging context for behavioral medicine research. J Consult Clin Psychol 2002; 70:712–772.
  7. Woodman R, Ferrucci L, Guralnik J. Anemia in older adults. CurrOpinHematol2005;12:123–128.
  8. Rostami Z, Hosseini MS, Lessan Pezeshki M, Heidari F, Einollahi B. Bone mineral metabolism and subsequent hospitalization with poor quality of life in dialysis patients. Nephrourol Mon 2014;6:e14944.
  9. Acchiardo SR, Hatten KW, Ruvinsky MJ, Dyson B, Fuller J, Moore LW. Inadequate dialysis increases gross mortality rate. ASAIOJ 1992;38:M282–M285.
  10. Mailloux LU, Bellucci AG, Wilkes BM, Napolitano B, Mossey RT, Lesser M, et al. Mortality in dialysis patients: analysis of the causes of death.Am J Kidney Dis. 1991; 18:326.
  11. Barberis N, Costa S, Gitto L, et al. (2016) Role of emotional intelligence as a mediating factor between uncertainty and anxiety hospital in chronic renal patients. Illn, Crisis Loss 27: 71–86.
  12. Sadeghpour F, Heidarzadeh M, Naseri P, et al. (2021) Emotional intelligence as a predictor of posttraumatic growth in patients undergoing hemodialysis. Illn, Crisis Loss 29: 131–142.
  13. Stack AG. Determinants of modality selection among incident US dialysis patients: results from a national study. J Am Soc Nephrol. 2002;13:1279-1287.
  14. Miskulin DC, Meyer KB, Athienites NV, et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE study. Am J Kidney Dis. 2002;39:324-336.
  15. Jager KJ, Korevaar JC, Dekker FW. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in the Netherlands. Am J Kidney Dis. 2004;43:891-899.
  16. Chaudhary K, Sangha H, Khanna R. Peritoneal dialysis first: rationale. Clin J Am Soc Nephrol. 2011;6:447-456.                                                                                           
  17. https://ada.com/conditions/chronic-renal-failure
  18. Textor SC. Ischemic nephropathy: where are we now? J Am SocNephrol. 2004 Aug;15(8):1974-82.
  19. Kitamoto Y, Tomita M, Akamine M, Inoue T, Itoh J, Takamori H, Sato T. Differentiation of hematuria using a uniquely shaped red cell. Nephron. 1993;64(1):32-6.
  20. Khanna R. Clinical presentation & management of glomerular diseases: hematuria, nephritic &nephrotic syndrome. Mo Med. 2011 Jan-Feb;108(1):33-6.
  21. Aeddula NR, Baradhi KM. StatPearls Publishing; Treasure Island (FL): May 22, 2023. Reflux Nephropathy.
  22. Madero M, García-Arroyo FE, Sánchez-Lozada LG. Pathophysiologic insight into MesoAmerican nephropathy. CurrOpinNephrolHypertens. 2017 Jul;26(4):296-302.
  23. Centers for Disease Control and Prevention. “Chronic Kidney Disease Basics.” December 2017. Accessed May 17, 2018.
  24. Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017 Mar 25;389(10075):1238-1252.
  25. Aeddula NR, Bardhan M, Baradhi KM. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Sep 12, 2022. Sickle Cell Nephropathy.
  26. National Kidney Foundation. “About Chronic Kidney Disease.” February 2017. Accessed May 17, 2018.
  27. Polycystic Kidney Disease Charity. “About PKD.” Accessed May 17, 2018.
  28. National Kidney Foundation. “What is Glomerulonephritis?” 2015. Accessed May 17, 2018.
  29. Anderson S, Rennke HG, Brenner BM. Antihypertensive therapy must control glomerular hypertension to limit glomerular injury. J Hypertens Suppl. 1986 Dec;4(5):S242-4.
  30. Yu HT. Progression of chronic renal failure. Arch Intern Med. 2003 Jun 23;163(12):1417-29.
  31. Brenner BM, Meyer TW, Hostetter TH (1982). "Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease". N Engl J Med. 307 (11): 652–9.
  32. Brenner BM, Lawler EV, Mackenzie HS (1996). "The hyperfiltration theory: a paradigm shift in nephrology". Kidney Int. 49 (6): 1774–7.
  33. Rüster C, Wolf G (2006). "Renin-angiotensin-aldosterone system and progression of renal disease". J Am Soc Nephrol. 17 (11): 2985–91.
  34. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM (1981). "Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation". Am J Physiol. 241 (1): F85–93.
  35. "Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases". Kidney Int Suppl. 75: S15–21 .
  36. Hostetter TH, Rennke HG, Brenner BM (1982). "The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies". Am J Med. 72 (3): 375–80.
  37. Anderson S, Meyer TW, Rennke HG, Brenner BM (1985). "Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass". J Clin Invest. 76 (2): 612–9.
  38. Meyer TW, Anderson S, Rennke HG, Brenner BM (1987). "Reversing glomerular hypertension stabilizes established glomerular injury". Kidney Int. 31 (3): 752–9.
  39. Wolf G, Ritz E (2005). "Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications". Kidney Int. 67 (3): 799–812.
  40. Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F (2002). "Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors". Kidney Int. 61 (6): 1986–95.
  41. Hong HJ, Chan P, Liu JC, Juan SH, Huang MT, Lin JG; et al. (2004). "Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells". Cardiovasc Res. 61 (1): 159–68.
  42. Crowley SD, Frey CW, Gould SK, Griffiths R, Ruiz P, Burchette JL; et al. (2008). "Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension". Am J Physiol Renal Physiol. 295 (2): F515–24. .
  43. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J (2003). "Inflammation and angiotensin II". Int J Biochem Cell Biol. 35 (6): 881–900.
  44. Wolf G (1998). "Link between angiotensin II and TGF-beta in the kidney". Miner Electrolyte Metab. 24 (2–3): 174–80 .
  45. Kalluri R, Neilson EG (2003). "Epithelial-mesenchymal transition and its implications for fibrosis". J Clin Invest. 112 (12): 1776–84.
  46. MedlinePlus. “Chronic kidney disease.” August 2017. Accessed May 17, 2018.
  47. National Kidney Foundation. “About Chronic Kidney Disease.” February 2017. Accessed May 17, 2018.
  48. American Kidney Fund. “Chronic Kidney Disease.” Accessed May 17, 2018.
  49. Centers for Disease Control and Prevention. “Chronic Kidney Disease Basics.” December 2017. Accessed May 17, 2018.
  50. https://www.mayoclinic.org/diseases-conditions/chronic-kidney-disease/diagnosis-treatment/drc-20354527.
  51. American Diabetes Association. Chronic Kidney Disease (https://diabetes.org/diabetes/chronic-kidney-disease).
  52. American Kidney Fund. Chronic Kidney Disease (https://www.kidneyfund.org/all-about-kidneys/chronic-kidney-disease-ckd).
  53. Centers for Disease Control and Prevention (U.S.). Chronic Kidney Disease Basics (https://www.cdc.gov/kidneydisease/basics.html).
  54. Donate Life America. Kidney Donation (https://www.donatelife.net/types-of-donation/kidney-donation/).
  55. Merck Manual, Consumer Version. Chronic Kidney Disease (https://www.merckmanuals.com/home/kidney-and-urinary-tract-disorders/kidney-failure/chronic-kidney-disease).
  56. National Institute of Diabetes and Digestive and Kidney Diseases (U.S.). What is Chronic Kidney Disease? (https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd).
  57. National Kidney Foundation. Chronic Kidney Disease (CKD) Symptoms and Causes (https://www.kidney.org/atoz/content/about-chronic-kidney-disease).
  58. https://www.mayoclinic.org/diseases-conditions/chronic-kidney-disease/diagnosis-treatment/drc-20354527.
  59. Suhail Ahmad. Manual of Clinical Dialysis (Paperback). Published by Springer, 16 Nov 2014. 
  60. Schilthuizen, S.F., et al., Device for the removal of toxic substances from blood, 2015, Google Patents.
  61. Preus, A., Historical dictionary of Ancient Greek philosophy 2015: Rowman & Littlefield.
  62. Soykan, O., C. Schu, and K.A. Chaffin, Method and device to treat kidney disease, 2014, Google Patents.
  63. Singbartl, K. and J.A. Kellum, Urinary Biomarkers for Predicting Long-Term Dialysis, 2014, Google Patents.
  64. Chamney, P., et al., Haemodialysis techniques and adequacy 2. Nephrology Dialysis Transplantation, 2014. 29(suppl 3): p. iii458-iii469.
  65. Wong, J., E. Vilar, and K. Farrington, Haemodialysis. Medicine, 2015. 43(8): p. 478-483.
  66. Chula DC, Campos RP, de Alcântara MT, Riella MC, do Nascimento MM. Percutaneous and surgical insertion of peritoneal catheter in patients starting in chronic dialysis therapy: a comparative study. Semin Dial. 2014;27(3):E32–E37.
  67. de Moraes TP, Campos RP, de Alcântara MT, et al; Investigators of BRAZPD. Similar outcomes of catheters implanted by nephrologists and surgeons: analysis of the Brazilian peritoneal dialysis multicentric study. Semin Dial. 2012;25(5):565–568.
  68. Medani S, Hussein W, Shantier M, Flynn R, Wall C, Mellotte G. Comparison of percutaneous and open surgical techniques for first-time peritoneal dialysis catheter placement in the unbreached peritoneum. Perit Dial Int. Epub July 31, 2014.
  69. Oliver MJ, Quinn RR, Richardson EP, Kiss AJ, Lamping DL, Manns BJ. Home care assistance and the utilization of peritoneal dialysis. Kidney Int. 2007;71(7):673–678.
  70. Povlsen JV, Ivarsen P. Assisted automated peritoneal dialysis (AAPD) for the functionally dependent and elderly patient. Perit Dial Int. 2005; 25 Suppl 3:S60–S63. 
  71. Verger C, Duman M, Durand PY, Veniez G, Fabre E, Ryckelynck JP. Influence of autonomy and type of home assistance on the prevention of peritonitis in assisted automated peritoneal dialysis patients. An analysis of data from the French Language Peritoneal Dialysis Registry. Nephrol Dial Transplant. 2007;22(4):1218–1223.
  72. 13.Al-Hwiesh A, Abdul-Rahman I, Finkelstein F, et al. Acute Kidney Injury in Critically Ill Patients: A Prospective Randomized Study of Tidal Peritoneal Dialysis Versus Continuous Renal Replacement Therapy. Ther Apher Dial. 2018;22(4):371-379.
  73. 14.Khan SF. Peritoneal Dialysis as a Renal Replacement Therapy Modality for Patients with Acute Kidney Injury.J Clin Med. 2022;11(12):3270.
  74. 15.Shetty A, Georgopoulos DG. Peritoneal dialysis:its indications and contraindica-tions. Dialysis & Transplantation 2000;29(2):71-77.
  75. https://www.kidney.org/atoz/content/dialysisinfo).
  76. National Kidney Foundation. (2020). KDOQI Clinical Practice Guideline for Diabetes and CKD: 2020 Update.
  77. Levey AS, et al. (2003). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.
  78. KDIGO CKD Work Group. (2013). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
  79. Centers for Disease Control and Prevention (CDC). Chronic Kidney Disease Surveillance System – United States.
  80. James MT, et al. (2010). Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study.
  81. Eckardt KU, et al. (2009). Evolving importance of kidney disease: from subspecialty to global health burden.
  82. Coresh J, et al. (2007). Prevalence of chronic kidney disease in the United States.
  83. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2012). KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
  84. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). (2020). Kidney Disease Statistics for the United States.
  85. Webster AC, et al. (2017). Chronic kidney disease.
  86. Hwang SJ, et al. (2003). Impact of age on the association between renal function and cardiovascular disease.
  87. Hill NR, et al. (2016). Global prevalence of chronic kidney disease – a systematic review and meta-analysis.
  88. Gansevoort RT, et al. (2013). Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
  89. Jha V, et al. (2013). Chronic kidney disease: global dimension and perspectives.
  90. Inker LA, et al. (2012). Estimating glomerular filtration rate from serum creatinine and cystatin C.
  91. Matsushita K, et al. (2010). Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.
  92. Muntner P, et al. (2012). Cardiovascular risk prediction in adults with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.
  93. Hallan SI, et al. (2006). Age and association of kidney measures with mortality and end-stage renal disease.
  94. Fox CS, et al. (2012). Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.
  95. Hemmelgarn BR, et al. (2010). Relation between kidney function, proteinuria, and adverse outcomes.
  96. Chronic Kidney Disease Prognosis Consortium, Matsushita K, et al. (2012). Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
  97. Levin A, et al. (2017). Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy.
  98. Xie Y, et al. (2014). Longitudinal relationships between serum urate and diabetes risk.
  99. Zhang L, et al. (2008). Prevalence of chronic kidney disease in China: a cross-sectional survey.
  100. Jha V, et al. (2016). Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference.
  101. Levey AS, et al. (2011). A new equation to estimate glomerular filtration rate.
  102. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD).
  103. Coresh J, et al. (2014). Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.
  104. Hallan SI, et al. (2009). Screening strategies for chronic kidney disease in the general population: follow-up of cross-sectional health survey.
  105. Stevens LA, et al. (2011). Estimating GFR using serum cystatin C alone and in combination with serum creatinine.

Photo
Nivetha B.
Corresponding author

Department of Pharmacy Practice, Excel College of  Pharmacy ,Namakkal District Tamil Nadu.

Photo
Manivannan R.
Co-author

Department of Pharmacy Practice, Excel College of  Pharmacy ,Namakkal District Tamil Nadu.

Photo
Arunkumar P.
Co-author

Department of Pharmacy Practice, Excel College of  Pharmacy ,Namakkal District Tamil Nadu.

Photo
Gokul V
Co-author

Department of Pharmacy Practice, Excel College of  Pharmacy ,Namakkal District Tamil Nadu.

Photo
Satheeshkumar R.
Co-author

Department of Pharmacy Practice, Excel College of  Pharmacy ,Namakkal District Tamil Nadu.

Photo
Sathya V.
Co-author

Department of Pharmacy Practice, Excel College of  Pharmacy ,Namakkal District Tamil Nadu.

Photo
Sudharsanan G.
Co-author

Department of Pharmacy Practice, Excel College of  Pharmacy ,Namakkal District Tamil Nadu.

Nivetha B. , Manivannan R. , Arunkumar P. , Gokul V. , Satheeshkumar R. , Sathya V. , Sudharsanan G., Assessing The Benefits, Risks, Psychological Issues And Costeffective Analysis In Peritoneal Dialysis And Hemodialysis, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 1, 675-787. https://doi.org/10.5281/zenodo.10579412

More related articles
Ayurvedic Remedies of Bacterial Meningitis...
Komal Ushir, Dinesh Rishipathak, Pragati Bhosale, Manisha Raut, ...
Hepatoprotective Effect of Curcumin Microsponges a...
Gaurav Kasar, Pooja Rasal, Ritesh Khairnar, Revati Khairnar, Shub...
Microsponges: The Drug Delivery System...
Akshata V. Raut, Nakul Kathar , Ganjanan Sanap, ...
Analytical Method Development And Validation For Simultaneous Estimation Of Anti...
Kartik A. Bhatkar, V. M. Waghulkar, M. P. Jadhao, M. D. Game, S. G. Jawarkar, ...
Pharmacognostical, Phytochemical Characterisation and Formulative Study of Trich...
S. Jasbin Nisha, Abish Mobin M., Deepthi Dileep, Thomas R., Daniel Xavier Prasad, Surabhi G. S., Pra...
Related Articles
Shaping Health Horizons: The Dynamic Impact Of Innovative Public Health Awarenes...
Nilima N. Khakal, Udayanraj M. Bhosale, Suraj B. Kumbhar, Vikram R. Shinde, N. H. Aloorkar, Dipak D....
Formulation and in vitro evaluation of floating pulsatile drug delivery system o...
Sajan Maharjan, Bhaskar Shrestha, Himal Chhetry, Panna Thapa, ...
Cardiovascular And Metabolic Abnormalities Induced By Antipsychotic Drug Therapy...
Benson P Wilson , Sona sojan, Athul Krishna SA , Assish p Antony , Happy Thomas , ...
A Review On : Development And Evaluation Of Efficacy Of Herbal Mosquito Repellan...
Priyanka D. Gaikwad, Apeksha N. Chavhat, Pratik P. Wani, Meghana Rayjade, ...
Ayurvedic Remedies of Bacterial Meningitis...
Komal Ushir, Dinesh Rishipathak, Pragati Bhosale, Manisha Raut, ...
More related articles
Ayurvedic Remedies of Bacterial Meningitis...
Komal Ushir, Dinesh Rishipathak, Pragati Bhosale, Manisha Raut, ...
Hepatoprotective Effect of Curcumin Microsponges against Paracetamol Induced Liv...
Gaurav Kasar, Pooja Rasal, Ritesh Khairnar, Revati Khairnar, Shubham Khaire, Yunus Ansari, Manoj Mah...
Microsponges: The Drug Delivery System...
Akshata V. Raut, Nakul Kathar , Ganjanan Sanap, ...
Ayurvedic Remedies of Bacterial Meningitis...
Komal Ushir, Dinesh Rishipathak, Pragati Bhosale, Manisha Raut, ...
Hepatoprotective Effect of Curcumin Microsponges against Paracetamol Induced Liv...
Gaurav Kasar, Pooja Rasal, Ritesh Khairnar, Revati Khairnar, Shubham Khaire, Yunus Ansari, Manoj Mah...
Microsponges: The Drug Delivery System...
Akshata V. Raut, Nakul Kathar , Ganjanan Sanap, ...